Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter MLANA Antikörper

MLANA Reaktivität: Human, Maus, Ratte, Hund IHC, ISt, StM Wirt: Kaninchen Monoclonal MLANA-1409R unconjugated Recombinant Antibody
Produktnummer ABIN6939401
  • Target Alle MLANA Antikörper anzeigen
    MLANA (Melan A (MLANA))
    Antikörpertyp
    Recombinant Antibody
    Reaktivität
    • 184
    • 108
    • 84
    • 32
    • 15
    Human, Maus, Ratte, Hund
    Wirt
    • 96
    • 87
    • 1
    Kaninchen
    Klonalität
    • 111
    • 73
    Monoklonal
    Konjugat
    • 68
    • 15
    • 8
    • 8
    • 8
    • 8
    • 8
    • 8
    • 5
    • 5
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Dieser MLANA Antikörper ist unkonjugiert
    Applikation
    • 126
    • 98
    • 97
    • 77
    • 57
    • 53
    • 26
    • 26
    • 23
    • 21
    • 12
    • 10
    • 8
    • 1
    • 1
    • 1
    Immunohistochemistry (IHC), Immunostaining (ISt), Staining Methods (StM)
    Spezifität
    This antibody recognizes a protein doublet of 20-22 kDa, identified as MART-1 (Melanoma Antigen Recognized by T cells 1) or Melan-A. MART-1 is a newly identified melanocyte differentiation antigen recognized by autologous cytotoxic T lymphocytes. Seven other melanoma associated antigens recognized by autologous cytotoxic T cells include MAGE-1, MAGE-3, tyrosinase, gp100, gp75, BAGE-1, and GAGE-1. Subcellular fractionation shows that MART-1 is present in melanosomes and endoplasmic reticulum. This MAb labels melanomas and other tumors showing melanocytic differentiation. It is also a useful positive-marker for angiomyolipomas. It does not stain tumor cells of epithelial, lymphoid, glial, or mesenchymal origin.
    Aufreinigung
    Purified by Protein A/G
    Immunogen
    Recombinant full-length hMART-1 protein
    Klon
    MLANA-1409R
    Isotyp
    IgG
    Top Product
    Discover our top product MLANA Primärantikörper
  • Applikationshinweise

    Positive Control: SK-MEL-13 and SK-MEL-19 melanoma cell lines. Human melanoma tissues.

    Known Application: Immunohistochemistry (Formalin-fixed) (0.5-1 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues is enhanced by boiling tissue sections in 10 mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    200 μg/mL
    Buffer
    10 mM PBS with 0.05 % BSA & 0.05 % azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-80 °C
    Informationen zur Lagerung
    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
    Haltbarkeit
    24 months
  • Target
    MLANA (Melan A (MLANA))
    Andere Bezeichnung
    MLANA (MLANA Produkte)
    Synonyme
    A930034P04Rik antikoerper, Mart1 antikoerper, MART-1 antikoerper, MART1 antikoerper, melan-A antikoerper, Mlana antikoerper, MLANA antikoerper
    Molekulargewicht
    20-22kDa (doublet)
    Gen-ID
    2315
    UniProt
    Q16655
Sie sind hier:
Kundenservice